Mumbai: The COVID-19 vaccine, co-developed by the University of Oxford and drug manufacturer AstraZeneca, is likely to get emergency use approval first in India, a report has claimed.
Quoting unnamed “official sources”, PTI has reported that the vaccine would be approved here after the United Kingdom gives a go-ahead. The Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford Covid-19 vaccine next week.
The vaccine known as Covishield is being manufactured by the Pune-based Serum Institute of India.
“Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on COVID-19 at the CDSCO will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here,” PTI said quoting unnamed official sources.
The emergency approvals for Bharat BioTech’s Covaxin will take time as it is still in Phase 3 trials.
Also Read: Pork Among Ingredients? Muslim Clerics Raise Concern Over Vaccine
New Delhi: The central government has sent a notice to Wikipedia—which endorses itself as a…
Bhubaneswar: Four journalists from Odisha sustained critical injuries when as the SUV carrying them rammed…
Puri: Gajapati Maharaja Dibyasingha Deb on Tuesday said legal action would be initiated against International…
New Delhi: In a big relief to about 16,000-odd madrasas in Uttar Pradesh, the Supreme…
Bhubaneswar: A young man, stated to be a social worker, was critically injured after being…
Off with his head', orders the Queen of Hearts and off goes a head. The…
Ottawa: A Canadian cop, identified as Sergeant Harinder Sohi—a Peel Regional Police officer— was reportedly…
Koraput: In a shocking incident, A woman was allegedly killed after the assailants tied her…